Enable Accessibility Enable Accessibility

Retail Investor Resource Hub 

Sign up for email alerts from Takeda


 

 

 

 

Takeda Stories

 

 

Takeda Highlights

Global
biopharmaceutical company
with presence in approx.

01


80 countries
and regions

Approx.

$29.4BNUSD revenue

02

 

in FY2021

Planned R&D investment of
approx.

$4.7BN1 USD

03

in FY2022 to support 
our innovative pipeline

Approx. 40 new molecular
entities
(NMEs)
in the pipeline

04

Including 10 late-stage
development programs

Ranked
6th overall
in the 2021 Access to
Medicine (AtM) Index

05

Industry leader in
"Governance of Access"

Named

Global Top Employer

06


for five
consecutive years

Achieved
Carbon neutrality
in value chain in FY2020

07


On track for carbon zero
status by 2040

Targeting
2x (i.e. "low-twos")

08


Net Debt / Adjusted
EBITDA2 ratio in
FY2021-FY2023

Best-in-class
governance

09


Board comprising
15 experienced global leaders,
including 11 independent
external directors3

 

Stock Information

As of March 2022. References: FY2021 Investor Presentation; Corporate Overview
1USD included for reference, calculated at JPY/USD of 121.44
2Non-IFRS measure. Further information on this and other Takeda Non-IFRS measures is posted on Takeda’s investor relations website
3As defined by Tokyo Stock Exchange Securities Listing Regulations

 

 

Investor Events

Check back for event calendar updates or sign up for email alerts straight to your inbox. 

 

 

Featured

Takeda has published its 2022 Annual Integrated Report

Find out how our financial and other impacts are creating value in the short, medium and long term, and the focus areas we believe are most important for the stakeholders and communities we serve. READ MORE

 

 

Innovation at Takeda

Our world-class R&D engine is focused on developing medicines and vaccines that will have a lasting impact on society and can make a critical difference to the lives of patients with limited or no options for treatment.

 

 


Frequently Asked Questions

General Information

Our 146th Ordinary General Meeting of Shareholders was held on June 29, 2022. Please visit our Annual Shareholders Meeting page for more information.

You may contact a licensed stockbroker or go through any registered broker-dealer to purchase shares of Takeda.

Takeda’s common shares are traded on the Tokyo Stock Exchange using stock code “4502.” Our ADSs are traded on the New York Stock Exchange using the symbol “TAK”. 

An American Depositary Receipt (ADR) is a certificate representing ownership of American Depositary Shares (ADSs) in a non-U.S. corporation. They include the right to attend and vote at AGMs, the receipt of dividends, and other common shareholder rights. One ADS represents 0.5 shares of Takeda’s common stock.  

Click here to learn more about Takeda’s historic share price performance.

Takeda’s largest shareholders and other share data, as most recently reported, can be found here. 

 

Dividend Information

Takeda has maintained a well-established dividend policy of 180 yen per share annually. Information on historical dividends paid by Takeda can be found here

Takeda’s  dividend payments have historically been issued on a semi-annual basis in June and December. The record date for year-end dividends is March 31 of each year. The record date for interim dividends is September 30 of each year. 

 

Financial Information

Takeda’s fiscal year ends on March 31st. You can find our earnings materials and dates on our financial results webpage.

Takeda’s official reporting currency is the yen.

Takeda follows the International Financial Reporting Standards, or IFRS, for its financial reporting.

For historic financial highlights of Takeda, please refer to our Financial Highlights page.

 

Additional Information

To send a comment or question to Takeda Pharmaceutical Company Limited, please visit: https://www.takeda.com/who-we-are/contact-us/

To subscribe to email alerts from Takeda, please use the form at the top of this page.


 

For feedback or inquiries, please visit https://www.takeda.com/who-we-are/contact-us/

Select the alerts you’d like to receive: * Indicates required field

At least one alert must be selected

Select one of the following:

Takeda will use the contact information you entered above to provide you with the investor related materials you requested. In order to best serve and effectively communicate with you, Takeda may also use your personal data for advertising purposes, such as serving you targeted advertisements related to the information you requested.  For more information on how Takeda processes your personal data and your rights related to this processing, please refer to our Privacy Notice and Terms of Use.